Browsing by Author Mastropasqua, Mauro G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2008Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trialCoates, Alan; Altermatt, Hans J; Braye, Stephen; Castiglione-Gertsch, Monica; Del Curto, Barbara; Dell'Orto, Patrizia; Gelber, Richard D. (Prof); Goldhirsch, A; Gusterson, Barry; Henriksen, Katrine L; Lacroix-Triki, Magali; Lykkesfeldt, Anne E; Mastropasqua, Mauro G.; Mery, Eliane; Price, K. N.; Rasmussen, Brigitte B; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthAdjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial, The Lancet, vol.9, N/A, 2008,pp 23-28
2010Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et al, various; Giobbie-Hurder, Anita; Gusterson,, B; Maiorano, Eugenio; Mallon, Elizabeth; Mastropasqua, Mauro G.; Sonzogni, A; Viale, Giuseppe; School of Public Health: Public HealthAdverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer., Annals of Oncology, vol.21, 2,pp 245-254
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2010Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerCoates, Alan; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Gusterson, Barry; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen N.; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthClassical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.28, 18, 2010,pp 2966-2973
2008Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancerCoates, Alan; Colleoni, Marco; et al, various; Golouh, Rastko; Maffini, Fausto; Maiorano, Eugenio; Mastropasqua, Mauro G.; Perin, Tiziana; Price, K N; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPredictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer, Journal of the National Cancer Institute, vol.100,(3),2008,pp 207-212
2010Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapyCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, A; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPrognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy, Breast Cancer Research and Treatment, vol.121, 1,pp 211-218
2007Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Women With Early Breast Cancer: Results From the BIG 1-98 Collaborative GroupsCoates, Alan; Dell'Orto, Patrizia; et, al; Maiorano, Eugenio; Mastropasqua, Mauro G.; Neven, Patrick; Orosz, Zsolt; Raffoul, Johnny; Rasmussen, Brigitte B; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPrognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Women With Early Breast Cancer: Results From the BIG 1-98 Collaborative Groups, Journal of Clinical Oncology, vol.25,(25),2007,pp 3846-3852
2008Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With LetrozoleCoates, Alan; Braye, Stephen; Dell'Orto, Patrizia; et al, Various; Giobbie-Hurder, Anita; MacGrogan, Gaetan; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPrognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole, Journal of Clinical Oncology, vol.26, 34, 2008,pp 5569-5575
2006Re-evaluating adjuvant breast cancer trials: Assessing hormone receptor status by immunohistochemical versus extraction assays.Coates, Alan; Brown, Bob; Carbone, Antonino; et, al; Golouh, Rastko; Langman, Gerald; Maiorano, Eugenio; Mastropasqua, Mauro G.; Regan, Meredith M.; Suurk├╝la, Mart; Viale, Giuseppe; School of Public Health: Public HealthRe-evaluating adjuvant breast cancer trials: Assessing hormone receptor status by immunohistochemical versus extraction assays., Journal of the National Cancer Institute, February 2005, vol.98,(21),2006,pp 1571-1581